THREE-PART PRICING TO REWARD PHARMACEUTICAL INNOVATION AND INCREASE ACCESS: CASE OF PCSK9 INHIBITORS

Authors

CHENG W HLÁVKA Jakub SNOWBERG Erik VAN NUYS Karen GOLDMAN Dana P.

Year of publication 2018
Type Conference abstract
Citation

You are running an old browser version. We recommend updating your browser to its latest version.

By clicking “Accept Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Settings

Necessary Only Accept Cookies